Cargando…
Sarcopenia Screening Allows Identifying High-Risk Patients for Allogenic Stem Cell Transplantation
SIMPLE SUMMARY: Allogenic stem cell transplantation is a treatment option for various hematological diseases. Due to the intensity of the therapy regimes used, there is a substantial therapy associated mortality and morbidity. Therefore, it is crucial to identify patients with increased risk for tre...
Autores principales: | Kirsten, Johannes, Wais, Verena, Schulz, Sebastian V.W., Sala, Elisa, Treff, Gunnar, Bunjes, Donald, Steinacker, Jürgen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068111/ https://www.ncbi.nlm.nih.gov/pubmed/33917738 http://dx.doi.org/10.3390/cancers13081771 |
Ejemplares similares
-
Monitoring of strength, inflammation and muscle function in allogenic stem-cell transplantation patients – a pilot study for novel biomarker and risk stratification determination
por: Schulz, Sebastian Viktor Waldemar, et al.
Publicado: (2023) -
Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients
por: Greiner, Jochen, et al.
Publicado: (2019) -
COVID-19 Vaccination after Allogeneic Stem Cell Transplantation: Real Word Data on Safety and Efficacy. a Single Center Experience.
por: Neagoie, Adela, et al.
Publicado: (2021) -
Inter- and intra-unit reliability of the COSMED K5: Implications for multicentric and longitudinal testing
por: Winkert, Kay, et al.
Publicado: (2020) -
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation
por: Hütter-Krönke, Marie Luise, et al.
Publicado: (2023)